Replies to post #345223 on Anavex Life Sciences Corp (AVXL)

[McMagyar]

Thx falconer I truly appreciate your input..

Perhaps what I am missing..
Are the posters like myself
whose limited biology knowledge
allows them to see things differently
Like Ted Lasso coaching soccer..

Yes there are some potentially dangerous assumptions..

A3-71 is as potent an S1r agonist as a3-72, without the metabolite power a3-72..

Ok.. but.. a3-71 has no known digestive limit to dosing..again.. safety AND minimal(zero) negative side effects.



Now.. a3-72 has married and repeated its animal clinical trials very closely..
Yes.. it’s an assumption that a3-71 will do the same. But the molecules are derived in a similar form.. so it’s not a leap and jump .. it’s just a step..and now since we have proved safe… it’s a safe step..


SAFE

So please all you dreamers.. let us delve a little deeper .. pretend like a3-71 is our first and only drug..what are the ten year possibilities of helping people..

[jimmy_mcyoloswag]

The counterarguments will probably retreat into a corner along the lines of:

"bUt iT iS oNlY iN mIcE!"
"iT's NoT dOuBlE bLiNdEd PlAcEbO!"
"tHeY mEaSuReD tHe WrOnG sCoReS!"
"ThEy CaN't KeEp ThEiR tImElInEs!"
"MiSsLiNg Is A dOo DoO hEaD wItH sTuPiD hAiR!"